Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
recombinant human follicle-stimulating hormone (JZB30)
- Development stage
- Phase 1
- Lead developer
- Shanghai Jingze Biotechnology
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Subcutaneous
01
Overview
Recombinant human follicle-stimulating hormone (JZB30) is a biosimilar therapeutic developed for use in assisted reproductive technology, specifically for controlled ovarian hyperstimulation (COH) and ovulation induction. It is designed to mimic the activity of endogenous follicle-stimulating hormone (FSH), which plays a key role in the regulation of reproductive processes by stimulating the growth and maturation of ovarian follicles in women and spermatogenesis in men. JZB30 has been evaluated for bioequivalence, safety, pharmacokinetics, immunogenicity, and efficacy compared to Gonal-f (the reference FSH product originally developed by Merck Serono). Clinical trials have included healthy adult female subjects as well as patients undergoing assisted reproduction or with idiopathic hypogonadotropic hypogonadism[1][2][3][5].
- Other names
- recombinant human follicle-stimulating hormone JZB30
02
Targets
FSHR (Follicle-stimulating hormone receptor)
Beyond the preview
Go deeper on recombinant human follicle-stimulating hormone (JZB30).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on recombinant human follicle-stimulating hormone (JZB30).